Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features (Q59706187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

prostate cancer screening

13 December 2019

main subject

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Jason S Krumholtz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Gustavo F Carvalhal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Christian G Ramos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Deborah S Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Phataraporn Thorson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Peter A Humphrey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Kimberly A Roehl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

William J Catalona

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

language of work or name

English

0 references

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

469-73; discussion 473-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Origin and development of carcinoma in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Prostate cancer. An overview of an increasing dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Serum prostate-specific antigen and the biologic progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901875-7

7 January 2021

10.1016/S0090-4295(02)01875-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12350486%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference